AstraZeneca (AZN), Merck (MRK) Enter Collaboration on Cancer Drug Lynparza; Will Receive $1.6B Upfront and Up to $8.5B
Tweet Send to a Friend
AstraZeneca (NYSE: AZN) and Merck & Co., Inc., (NYSE: MRK) today announced that they have entered a global strategic oncology ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
